The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial.

Autor: Papaefthymiou, Apostolis1,2 (AUTHOR) appapaef@hotmail.com, Sarrou, Styliani3 (AUTHOR) ssarrou@uth.gr, Pateras, Konstantinos4 (AUTHOR) kostas_pks@hotmail.com, Vachliotis, Ilias D.1,5 (AUTHOR) agoulas@auth.gr, Agrotis, Georgios6 (AUTHOR) g.agrotis@hotmail.com, Sgantzou, Ioanna-Konstantina6 (AUTHOR) iksgantzou@gmail.com, Perifanos, Georgios7 (AUTHOR) geoproud1@gmail.com, Kapsoritakis, Andreas2 (AUTHOR) spotam@med.uth.gr, Speletas, Matthaios3 (AUTHOR) maspel@med.uth.gr, Vlychou, Marianna6 (AUTHOR) mvlychou@med.uth.gr, Dalekos, George N.7 (AUTHOR) georgedalekos@gmail.com, Potamianos, Spyros2 (AUTHOR), Goulas, Antonis1 (AUTHOR) spolyzos@auth.gr, Kountouras, Jannis8 (AUTHOR) jannis@auth.gr, Polyzos, Stergios A.1 (AUTHOR)
Zdroj: Pharmaceuticals (14248247). Nov2024, Vol. 17 Issue 11, p1432. 16p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje